Historically, the prediction of CAD has been based on traditional cardiovascular risk factors and algorithms incorporating them, which provide an estimate of the risk of developing fatal and/or non-fatal coronary and other ASCVD events. The same source reports a decreasing trend in morbidity and mortality from CAD, which has occurred despite a worsening in the risk profiles of Americans with atherosclerotic cardiovascular disease (ASCVD), and is likely due to advances in the prediction, detection, and treatment of CAD. ![]() The American Heart Association 2022 statistical update reported a high prevalence and incidence of CAD, which affects 20.1 million Americans ≥20 years of age and is estimated to occur in 720,000 and 335,000 individuals as a new or recurrent (fatal or non-fatal) event, respectively. There exists the potential to identify the non-obstructive lesions at high risk of progression to plaque rupture by combining all of these measures.Ĭoronary artery disease (CAD) remains the main cause of morbidity and mortality in the world. ![]() Moreover, CCTA provides a unique incremental value over functional testing and ICA by imaging the vessel wall, thus allowing the assessment of plaque burden, composition, and instability features, in addition to perivascular adipose tissue attenuation, which is a marker of vascular inflammation. In addition, coronary CT angiography (CCTA) has become a gate-keeper to invasive coronary angiography (ICA) and revascularization in patients with acute chest pain by allowing the assessment not only of the extent of lumen stenosis, but also of its hemodynamic significance if combined with the measurement of fractional flow reserve or perfusion imaging. Coronary artery calcium, as assessed by non-contrast CT, is considered to be the best marker of subclinical atherosclerosis, and its use is recommended for the refinement of risk assessment in low-to-intermediate risk individuals. Advances in technology have favored the increasing use of cardiac CT by allowing better performance with lower radiation doses. MHHS, meanwhile, employs 6,700 affiliated physicians across 250 care sites, including 17 hospitals.In recent decades, cardiac computed tomography (CT) has emerged as a powerful non-invasive tool for risk stratification, as well as the detection and characterization of coronary artery disease (CAD), which remains the main cause of morbidity and mortality in the world. The firm bills itself as the largest radiology practice in the Houston metropolitan area, employing 95 physicians serving 12 hospitals and several outpatient imaging centers. Mednax first acquired Synergy Radiology Associates in a cash transaction consummated back in October 2017. Synergy’s “new breast division” will deploy trained subspecialized breast radiologists in collaboration with the health system across all care centers, the partners noted. ![]() “This collaboration allows us to extend our commitment even further and provides the opportunity for important and even lifesaving breast screenings for not only women but men as well.” “Memorial Hermann is ready to expand its partnership with Synergy and to continue to provide high quality care to communities throughout Greater Houston,” Heath Rushing, Memorial Hermann’s senior VP of service lines, said in a statement. All told, Synergy and Memorial Hermann operate nine specialized women’s imaging centers following the deal. ![]() The agreement covers seven additional outpatient imaging and breast care centers, delivering services ranging from diagnostic mammography to breast MRI, biopsies and ultrasound. Mednax affiliate Synergy Radiology Associates has inked a deal to expand breast imaging services at Houston hospital giant Memorial Hermann, the partners announced Thursday. Mednax affiliate Synergy Radiology inks deal to expand breast imaging at Houston hospital giantThe agreement covers seven additional outpatient imaging and breast care centers, Memorial Hermann and the Texas physician practice announced Thursday.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |